New technologies have enabled the potential for stratified medicine in psoriasis. It is important to understand patients’ preferences to enable the informed introduction of stratified medicine which is likely to …
Retrospective analysis of 578 inpatient dermatology consultations in hematology and hematopoietic stem cell transplant patients.
Hospitalized patients with hematologic malignancies are medically complex and commonly affected by dermatologic conditions.Retrospective chart review from January 1, 2014, to December 31, 2018, at Rochester Methodist Hospital (Rochester, Minnesota, …
Air pollution-induced tanning of human skin.
Melanism is more frequent in animals living in polluted areas at urban-industrial sites. Given that a growing part of the human population is exposed to elevated air pollution levels, we …
Clinical characteristics and long-term outcomes of 97 Korean patients with mycosis fungoides.
Mycosis fungoides (MF) shows racial and regional differences in terms of clinical features. The availability of therapeutic options as well as drugs differs from one country to another. There are …
Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic-Therapy-Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.
Fumaric acid esters (FAEs; Fumaderm® ) are the most frequently prescribed first-line systemic treatment for moderate-to-severe plaque psoriasis in Germany. Risankizumab (Skyrizi® ) is a humanized IgG1 monoclonal antibody that …
Time, Costs of Participation in MIPS Are Considerable
Mean cost to practices per physician $12,811; 201.7 hours annually spent per physician on MIPS-related activities